ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c; Reports Cash and Cash Equivalents of $11.8M

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Choiceone Financial Services, Inc. (COFS) Misses Q2 EPS by 5c
• Verizon Communications (VZ) Tops Q2 EPS by 2c, Misses on Revenue, Tops on Postpaid Adds